William J. Link Phd.
Director, INTRALASE CORP.
Companies
- RxSight, Inc.Board member Jul 29, 2021 to now1
- Tarsus Pharmaceuticals, Inc.Board member Oct 15, 2020 to now2
- LENSAR, Inc.Board member Sep 17, 2020 to now3
- Oyster Point Pharma, Inc.Board member Oct 30, 2019 to Jan 7, 20224
- GLAUKOS CorpBoard member Jun 24, 2015 to Jun 7, 20215
- Edwards LifesciencesBoard member May 11, 2009 to May 11, 20206
- Vivani Medical, Inc.Board member Nov 18, 2014 to Jun 5, 20197
- Flexion TherapeuticsBoard member Sep 12, 2014 to Sep 12, 20148
- Inogen IncBoard member Feb 12, 2014 to Feb 21, 20149
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tarsus Pharmaceuticals, Inc. TARS94,487 shares10$6.6M at $69.64Sep 15, 2026
- LENSAR, Inc. LNSR568,062 shares11$3.3M at $5.76Jun 3, 2026
- RxSight, Inc. RXST96,140 shares12$453.8K at $4.72Jun 18, 2026
- Oyster Point Pharma, Inc.424,673 shares13Jan 7, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 15, 2026Sold 66 shares at $80.01 of Tarsus Pharmaceuticals, Inc.10
- Sep 15, 2026Sold 759 shares at $79.00 of Tarsus Pharmaceuticals, Inc.10
- Sep 15, 2026Sold 11,675 shares at $78.33 of Tarsus Pharmaceuticals, Inc.10
- Sep 15, 2026Exercised options 201 shares of Tarsus Pharmaceuticals, Inc.10
- Jun 17, 2026Granted 37,037 shares of RxSight, Inc.12
- Jun 15, 2026Sold 1,928 shares at $62.94 of Tarsus Pharmaceuticals, Inc.14
- Jun 15, 2026Sold 10,572 shares at $61.97 of Tarsus Pharmaceuticals, Inc.14
- Jun 12, 2026Exercised options 2,954 shares of Tarsus Pharmaceuticals, Inc.15
- Jun 3, 2026Granted 17,421 shares of LENSAR, Inc.11
- Mar 16, 2026Sold 493 shares at $69.75 of Tarsus Pharmaceuticals, Inc.16
- Mar 16, 2026Sold 8,378 shares at $69.03 of Tarsus Pharmaceuticals, Inc.16
- Mar 16, 2026Sold 3,629 shares at $68.09 of Tarsus Pharmaceuticals, Inc.16
- Dec 15, 2025Sold 4,766 shares at $81.50 of Tarsus Pharmaceuticals, Inc.17
- Dec 15, 2025Sold 5,680 shares at $80.71 of Tarsus Pharmaceuticals, Inc.17
- Dec 15, 2025Sold 1,148 shares at $82.39 of Tarsus Pharmaceuticals, Inc.17
- Dec 15, 2025Sold 6,306 shares at $81.75 of Tarsus Pharmaceuticals, Inc.17
- Dec 15, 2025Sold 5,046 shares at $80.80 of Tarsus Pharmaceuticals, Inc.17
- Sep 16, 2025Gift 2,000 shares of Tarsus Pharmaceuticals, Inc.18
- Sep 8, 2025Sold 27,116 shares at $57.00 of Tarsus Pharmaceuticals, Inc.19
- Jun 13, 2025Exercised options 3,350 shares of Tarsus Pharmaceuticals, Inc.20
- Jun 3, 2025Granted 10,752 shares of RxSight, Inc.21
- May 23, 2025Granted 7,374 shares of LENSAR, Inc.22
- Aug 12, 2024Sold 5,021 shares at $26.53 of Tarsus Pharmaceuticals, Inc.23
- Aug 12, 2024Sold 29,979 shares at $26.01 of Tarsus Pharmaceuticals, Inc.23
- Aug 12, 2024Other 27,116 shares of Tarsus Pharmaceuticals, Inc.23
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRxSight, Inc., Board member
- 2
- 3SEC EDGARLENSAR, Inc., Board member
- 4
- 5SEC EDGARGLAUKOS Corp, Board member
- 6SEC EDGAREdwards Lifesciences, Board member
- 7SEC EDGARVivani Medical, Inc., Board member
- 8SEC EDGARFlexion Therapeutics, Board member
- 9SEC EDGARInogen Inc, Board member
- 10
- 11
- 12
- 13
- 14SEC EDGARForm 4 filed Jun 17, 2026
- 15SEC EDGARForm 4 filed Jun 16, 2026
- 16SEC EDGARForm 4 filed Mar 18, 2026
- 17SEC EDGARForm 4 filed Dec 17, 2025
- 18SEC EDGARForm 4 filed Sep 18, 2025
- 19SEC EDGARForm 4 filed Sep 10, 2025
- 20SEC EDGARForm 4 filed Jun 16, 2025
- 21SEC EDGARForm 4 filed Jun 4, 2025
- 22SEC EDGARForm 4 filed May 28, 2025
- 23SEC EDGARForm 4 filed Aug 14, 2024